The Valley Desk

ArticleScience translational medicinePublished

Selective abrogation of S6K2 identifies lipid homeostasis as a survival vulnerability in MAPK inhibitor-resistant NRAS-mutant melanoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names The Wistar Institute. Affiliation source

Publication record

Type
Article
Venue
Science translational medicine
Published
Subject terms
Cell Line, Tumor; Animals; Humans; Mice; Melanoma; GTP Phosphohydrolases; Mitogen-Activated Protein Kinases; Membrane Proteins; Protein Kinase Inhibitors; Xenograft Model Antitumor Assays; Cell Survival; Homeostasis
PubMed ID
39908352
PubMed Central ID
PMC12258192
Added to directory
Source checked

Report a correction or request removal